PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the signature of a 2009 co-promotion agreement with Lundbeck for the latter's Seroplex® antidepressant.